Igm Biosciences Inc (IGMS) - News Archive

Showing 4 of 4 results.

IGM Biosciences Hits a Roadblock: Autoimmunity Pipeline Programs Halted Amid $220 Million Loss as Market Soars,

IGM Biosciences Halts Key Pipeline Programs Amid Financial Struggles and Market Optimism IntroductionIn a significant strategic shift, IGM Biosciences Inc. announced it will halt further development of its promising aut...

Jan 9, 2025 • Major Pharmaceutical Preparations Industry Management Announcement

In this eventful week, the stock market continued to soar as the S&P 500 and Nasdaq reached new record highs, reflecting investors optimism amidst the Federal Reserve...

In a week filled with various market developments, the S&P 500 and Nasdaq closed at record highs as the Federal Reserve s Chairman prepared to testify before Congress. Alongside this news, Tyra Biosciences received and...

Jul 13, 2024 • Major Pharmaceutical Preparations Industry Stocks on the Move P Cowen Breakthrough Device Designation Nvidia Fri

A Strategic Turn in the Bio-Pharma Industry: IGM Biosciences and Sanofi Refocus Collaboration on Inflammatory Diseases.

In a significant strategic shift, IGM Biosciences, a clinical-stage biotechnology company focused on building integrated antibody solutions, has decided to refocus its collaboration with Sanofi, the French multinational...

Apr 17, 2024 • Major Pharmaceutical Preparations Industry Product Service News

Strategic Pipeline Prioritization and Cash Boost: Navigating Revenue Growth Challenges, IGM Biosciences Prepares for the Future.

In recent news, IGM Biosciences Inc has unveiled its strategic pipeline prioritization and extended its cash runway. The company has emphasized the clinical development of its DR5 agonist in colorectal cancer and T cell...

Dec 5, 2023 Clinical Study